Physicians and patients must read the black box warning in the package insert. Because of the risk of fatal aplastic anemia and liver failure, use should be reserved for patients...

Clinical experience with Felbatol following its approval by the FDA in the U.S. showed a significant risk of fatal aplastic anemia and liver failure. As a result, the use of Felbatol is now largely restricted to patients with Lennox-Gastaut...

A few people have serious reactions to Depakene. These problems are very rare but everyone who takes this medicine should at least be aware of them because a very small number of people have died because of them. Here's a list...

Most people who take Felbatol (felbamate) have no side effects or mild side effects that go away with no lasting harm. But a few people (about 1 in 4,500) have had serious reactions. Here's a list of symptoms that may be the start...

Most people who take Felbatol (felbamate) have no side effects or mild side effects that go away with no lasting harm. But a few people (about 1 in 4,500) have had serious reactions. Here's a list of symptoms that may be the start...

A few people have serious reactions to valproic acid. These problems are very rare but everyone who takes this medicine should at least be aware of them because a very small number of people have died because of them. Here's...

Most side effects from taking valproic acid go away with no lasting harm. But a few people have serious reactions that can even be life-threatening. Here's a list of symptoms that may be the start of one of these problems....

Felbatol is used for partial seizures—that is, seizures that begin in a limited area of the brain. Sometimes these seizures spread throughout the brain (generalize). It is approved to be used either by itself or as adjunctive therapy—that...

Felbatol can be used to treat both children and adults: Adults: used either alone (monotherapy) or in combination with other seizure medicines (adjunctive therapy)...